These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16220490)

  • 21. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective.
    Goldberg RJ; Spencer FA; Steg PG; Flather M; Montalescot G; Gurfinkel EP; Kennelly BM; Goodman SG; Dedrick R; Gore JM;
    Arch Intern Med; 2007 Sep; 167(16):1766-73. PubMed ID: 17846396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial infarction: an important factor for surgical decision making?
    Osswald BR; Tochtermann U; Keller S; Badowski-Zyla D; Gegouskov V; Thomas G; Jakob HG; Hagl S
    Thorac Cardiovasc Surg; 2009 Apr; 57(3):130-4. PubMed ID: 19330748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between time of statin initiation after hospital discharge from acute myocardial infarction and risk of recurrence and mortality in patients > or =65 years of age.
    Zhou Z; Rahme E; Pilote L
    Am J Cardiol; 2006 Jan; 97(2):155-9. PubMed ID: 16442354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods.
    Stukel TA; Fisher ES; Wennberg DE; Alter DA; Gottlieb DJ; Vermeulen MJ
    JAMA; 2007 Jan; 297(3):278-85. PubMed ID: 17227979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
    Chiu FC; Chang SN; Lin JW; Hwang JJ; Chen YS
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1326-30. PubMed ID: 19660378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating exposure effects by modelling the expectation of exposure conditional on confounders.
    Robins JM; Mark SD; Newey WK
    Biometrics; 1992 Jun; 48(2):479-95. PubMed ID: 1637973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk stratification in acute coronary syndromes--does the TIMI risk score work in unselected cases?
    Soiza RL; Leslie SJ; Williamson P; Wai S; Harrild K; Peden NR; Hargreaves AD
    QJM; 2006 Feb; 99(2):81-7. PubMed ID: 16410286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses.
    Fellahi JL; Parienti JJ; Hanouz JL; Plaud B; Riou B; Ouattara A
    Anesthesiology; 2008 Jun; 108(6):979-87. PubMed ID: 18497597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weaknesses of goodness-of-fit tests for evaluating propensity score models: the case of the omitted confounder.
    Weitzen S; Lapane KL; Toledano AY; Hume AL; Mor V
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):227-38. PubMed ID: 15386700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study.
    Holme I; Szarek M; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):315-20. PubMed ID: 19322096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
    Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
    Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction.
    Khan SQ; Quinn P; Davies JE; Ng LL
    Heart; 2008 Jan; 94(1):40-3. PubMed ID: 17488769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose normalization and outcomes in patients with acute myocardial infarction.
    Kosiborod M; Inzucchi SE; Krumholz HM; Masoudi FA; Goyal A; Xiao L; Jones PG; Fiske S; Spertus JA
    Arch Intern Med; 2009 Mar; 169(5):438-46. PubMed ID: 19273773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication.
    Segal JB; Griswold M; Achy-Brou A; Herbert R; Bass EB; Dy SM; Millman AE; Wu AW; Frangakis CE
    Med Care; 2007 Oct; 45(10 Supl 2):S149-57. PubMed ID: 17909374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
    Lenderink T; Boersma E; Gitt AK; Zeymer U; Wallentin L; Van de Werf F; Hasdai D; Behar S; Simoons ML
    Eur Heart J; 2006 Aug; 27(15):1799-804. PubMed ID: 16820364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.